The Valley Desk

NCT00516217 · Interventional trial

Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Overall registry status Completed

Phase 2

Conditions Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov